ITOS - iTeos Therapeutics' (ITOS) CEO Michel Detheux on Q2 2021 Results - Earnings Call Transcript
iTeos Therapeutics Inc. (ITOS) Q2 2021 Earnings Conference Call August 12, 2021 8:00 AM ET Company Participants Ryan Baker – Head-Investor Relations Michel Detheux – President and Chief Executive Officer Matthew Gall – Chief Financial Officer Joe Lager – Chief Medical Officer Conference Call Participants Chris Raymond – Piper Sandler Daina Graybosch – SVB Leerink Swayampakula Ramakanth – H.C. Wainwright Anupam Rama – JP Morgan Presentation Operator Good morning and welcome to the iTeos Therapeutics’ Second Quarter 2021 Financial Results Conference Call. My name is Emily and I will be your moderator today. At this time, all participants are in a listen-only mode. However, following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request. Now I'd like to turn over to Ryan Baker, Head of Investor Relations at iTeos, please proceed. Ryan Baker Thank
For further details see:
iTeos Therapeutics' (ITOS) CEO Michel Detheux on Q2 2021 Results - Earnings Call Transcript